Home/ Supplements/ Niacin/ Pro-Gest

Pro-Gest

product on market Tablet or Pill Integrative Therapeutics Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 11% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This formula contains Betaine HCl and Bromelain, which have moderate evidence for supporting digestive enzyme function and protein breakdown. Niacin and L-Glutamic Acid provide metabolic and amino acid support, though overall evidence coverage for this specific combination is limited. The ingredient profile maintains a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Pro-Gest
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
45
Servings
Other Combinations
Product Type
11%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Total Carbohydrates
1 Gram(s) (1% DV)
20 mg (125% DV)
1.4× RDA — within safe limits 196 studies (A:5, B:63)
310 mg
Market median: 496.0mg (192 products) 20 studies — no high-quality reviews
L-Glutamic Acid
310 mg
200 mg
Market median: 200.0mg (136 products) 3 studies — no high-quality reviews
Papain
200 mg
Amylase
150 mg
Lipase
100 mg
Ox Bile
32 mg

Other Ingredients

Cellulose Stearic Acid Sodium Carboxymethylcellulose Silicon Dioxide Hydroxypropyl Methylcellulose Magnesium Stearate Glycerin
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommendation: Take 2 tablets with meals, or as recommended by your healthcare professional.

Warnings & Precautions

Caution: Not recommended for use if peptic ulcer, gastritis, or heartburn are present.

If pregnant, nursing, or taking prescription drugs, consult your healthcare professional prior to use.

Keep out of reach of children.

Safety sealed with printed inner seal. Do not use if seal is broken or missing.

Contains milk.

Formulation Notes

Contains no sugar, salt, yeast, wheat, gluten, soy, artificial colors, flavors, or preservatives.

Contains milk.

Additional Information

LZ71459.D01 BLK145D

Protein Digesting Support

Keep bottle tightly closed in a dry place.

Metadata

Product Details

UPC / SKU8 71791 00251 7
DSLD Entry Date2019-04-25
Product TypeOther Combinations
FormTablet or Pill
BrandIntegrative Therapeutics
DSLD ID201214
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

Rezistaf
LifeLink · Tablet or Pill
100
Coenzymated B-3 25 mg
Source Naturals · Tablet or Pill
100
Vitamin B Complex
Simply Supplements · Tablet or Pill
100
Test X180 Boost
Force Factor · Tablet or Pill
100
8-Hour Alert
MHP Maximum Human Performance · Tablet or Pill
100
View all Niacin products →
Niacin research Best Niacin All Niacin products More from Integrative Therapeutics View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.